isocarboxazid has been researched along with Neuromuscular Diseases in 1 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirrane, R | 1 |
| Bodner, R | 1 |
| Lynch, T | 1 |
1 other study available for isocarboxazid and Neuromuscular Diseases
| Article | Year |
|---|---|
Response to "Sertraline and isocarboxazid cause a serotonin syndrome".
Topics: 1-Naphthylamine; Adult; Dextromethorphan; Drug Therapy, Combination; Female; Humans; Isocarboxazid; | 1995 |